Overview

Use of Impedance Cardiography to Decrease the Risk of Pre-eclampsia in Obese Patients

Status:
Unknown status
Trial end date:
2020-03-04
Target enrollment:
Participant gender:
Summary
To determine if the use of impedance cardiography can identify appropriate medications for use in treating morbidly obese patients to decrease the risk of preeclampsia.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Tennessee Graduate School of Medicine
Treatments:
Atenolol
Labetalol
Nifedipine